伊朗

Merck tests ground for Iran partnership to produce medicines
默克药业寻求在伊朗合作制药


临时核协议实施后,伊朗有望重新成为企业投资目的地,近期已多家欧洲企业到访伊朗

German pharmaceutical group Merck is seeking a partnership with an Iranian manufacturer to produce medicines in the country in a sign that western companies are putting their faith in President Hassan Rouhani’s reformist drive and an easing of international sanctions.

西方公司对伊朗总统哈桑•鲁哈尼(Hassan Rouhani)的改革意愿和国际制裁的缓和展现了信心。德国制药集团默克(Merck)正在寻求与一家伊朗厂商合作,在伊朗联合生产药品。

Dozens of European businesses have visited the country in recent months in anticipation of a thaw in relations over Iran’s nuclear programme that could rehabilitate the oil-rich country as a destination for business investment.

最近数月,数十家欧洲企业访问伊朗。他们预期伊朗核计划引发的紧张关系解冻,让这个富油的国家重新成为企业投资目的地。

您已阅读21%(640字),剩余79%(2389字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×